Gregory Crimmins, Thomas Polasek, Caroline Robb, Srikanth Pendyala, Michael Schelle, Timothy Jarvela, Banumathi Cole, Min Wu, Kelechi Joe-Nweke, Dennise De Jesús-Díaz. "First-in-human randomized placebo-controlled Phase 1 study of RPT1G, a novel hyperbolic NAMPT inhibitor for use in acute leukemias: Safety, pharmacokinetics, and pharmacodynamics in healthy volunteers." Blood, 2025. doi:10.1182/blood-2025-5044